Joanne J. Kurtzberg
Expertise in
2
conditions

Dr. Joanne J. Kurtzberg

Pediatric Hematology Oncology
Duke Health
Duke Children's Health Center Bone Marrow Transplant Clinic
2301 Erwin Rd, 
Durham, NC 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
46 Years of Experience

Expertise in
2
conditions
Duke Health
Duke Children's Health Center Bone Marrow Transplant Clinic
2301 Erwin Rd, 
Durham, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

I’m a pediatric blood and bone marrow transplant specialist. I see patients from all over the world, many of whom have very rare diseases. I take care of patients with leukodystrophies, leukemias and other blood disorders that are resistant to standard treatment, and children with brain injuries like cerebral palsy. It’s rewarding to make a difference when treating challenging diseases. I’ve been fortunate over my career to be able to develop new treatments in the laboratory that I take into the clinic to help patients. In fact, here at Duke I was involved in the first cord-blood transplant anywhere in the world. When meeting with patients, I focus on making their experience more than just the medicine. We have a family support program for things beyond medical needs, which is especially helpful for families that are far from home. Outside of work, I like to knit, bike and spend time with my family.

Dr. Kurtzberg is highly rated in 2 conditions, according to our data. Her top areas of expertise are Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), Congenital Athymia, Autism Spectrum Disorder, and Childhood Acute Myeloid Leukemia.

Her clinical research consists of co-authoring 198 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in NC
Board Certifications
American Board Of Pediatrics, General Pediatrics
American Board Of Pediatrics, Pediatric Hematology-Oncology
Fellowships
Pediatric Hematology-Oncology, Upstate Medical Center (New York), Pediatric Hematology-Oncology, Duke University Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 7 Less Insurance Carriers -

Locations

Duke Children's Health Center Bone Marrow Transplant Clinic
2301 Erwin Rd, Durham, NC 27710

Additional Areas of Focus

Dr. Kurtzberg has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

A Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)
A Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)
Enrollment Status: Recruiting
Publish Date: November 28, 2025
Intervention Type: Procedure, Biological
Study Drug: NRTX-1001
Study Phase: Phase 3
A Phase II Open Label Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Salvage of Treatment-Refractory Acute GVHD Patients
A Phase II Open Label Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Salvage of Treatment-Refractory Acute GVHD Patients
Enrollment Status: Completed
Publish Date: October 30, 2025
Intervention Type: Drug
Study Phase: Phase 2
Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases
Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases
Enrollment Status: Active_not_recruiting
Publish Date: September 05, 2025
Intervention Type: Procedure, Drug, Other, Biological
Study Phase: Phase 2
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
Enrollment Status: Completed
Publish Date: August 19, 2025
Intervention Type: Other
Study Phase: Not Applicable
Phase IA Trial of Intrathecal Administration of Human Umbilical Cord Blood-Derived Cell Therapy (DUOC-01) in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Phase IA Trial of Intrathecal Administration of Human Umbilical Cord Blood-Derived Cell Therapy (DUOC-01) in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Enrollment Status: Active_not_recruiting
Publish Date: January 28, 2025
Intervention Type: Biological
Study Drug: DUOC-01
Study Phase: Phase 1
A Phase II Study of hCT-MSC, an Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Children With Autism Spectrum Disorder
A Phase II Study of hCT-MSC, an Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Children With Autism Spectrum Disorder
Enrollment Status: Completed
Publish Date: February 14, 2024
Intervention Type: Biological, Other
Study Drug: Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells (hCT-MSC)
Study Phase: Phase 2
Allogeneic Stem Cell Transplantation of NiCord®, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies
Allogeneic Stem Cell Transplantation of NiCord®, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies
Enrollment Status: Completed
Publish Date: May 20, 2022
Intervention Type: Drug
Study Drug: NiCord Cord Blood Graft
Study Phase: Phase 1/Phase 2
A Single-arm, Prospective Study of Remestemcel-L, Ex-vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
A Single-arm, Prospective Study of Remestemcel-L, Ex-vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
Enrollment Status: Completed
Publish Date: March 17, 2022
Intervention Type: Drug
Study Phase: Phase 3
Multi-Center, Open-Label Randomized Study of Single or Double Myeloablative Cord Blood Transplantation With or Without Infusion of Off-The-Shelf Ex Vivo Expanded Cryopreserved Cord Blood Progenitor Cells in Patients With Hematologic Malignancies
Multi-Center, Open-Label Randomized Study of Single or Double Myeloablative Cord Blood Transplantation With or Without Infusion of Off-The-Shelf Ex Vivo Expanded Cryopreserved Cord Blood Progenitor Cells in Patients With Hematologic Malignancies
Enrollment Status: Completed
Publish Date: July 06, 2021
Intervention Type: Drug, Radiation, Procedure, Biological
Study Drugs: Cyclophosphamide, Cyclosporine, Fludarabine, Mycophenolate Mofetil, Thiotepa
Study Phase: Phase 2
Single Patient Expanded Access Protocol: Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
Single Patient Expanded Access Protocol: Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
Enrollment Status: No_longer_available
Publish Date: October 08, 2020
Intervention Type: Biological
View 9 Less Clinical Trials

198 Total Publications

Reconstitution of thymopoiesis via implantation of cryopreserved cultured thymus tissue into athymic recipients.
Reconstitution of thymopoiesis via implantation of cryopreserved cultured thymus tissue into athymic recipients.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: April 23, 2025
View All 198 Publications
Similar Doctors
John J. Strouse
Expertise in
11
conditions
Dr. John J. Strouse
Pediatric Hematology Oncology
Expertise in
11
conditions
Dr. John J. Strouse
Pediatric Hematology Oncology

Duke Adult Comprehensive Sickle Cell Center - Clinic 2N

40 Duke Medicine Cir, 
Durham, NC 
 (0.3 miles away)
919-684-6464
Languages Spoken:
English
See accepted insurances
Offers Telehealth

I became interested in medicine after studying tropical forest in college and realizing that I wanted more contact with people than trees. In medical school, I cared for children and adults with sickle cell disease and was inspired by the challenges and complexity of this chronic illness. I chose to train in both pediatric and adult hematology and now see both children and adults with non-malignant blood disorders. I joined Duke Health in July 2016 to direct the Adult Sickle Cell Program and focus on the care of children and adults with disorders of hemoglobin. Dr. Strouse is highly rated in 11 conditions, according to our data. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Expertise in
4
conditions
Dr. Paul E. Monahan
Pediatric Hematology Oncology
Expertise in
4
conditions
Dr. Paul E. Monahan
Pediatric Hematology Oncology
101 Manning Dr, 
Chapel Hill, NC 
 (9.6 miles away)
919-966-4131
Languages Spoken:
English

Paul Monahan is a Pediatric Hematologist Oncology provider in Chapel Hill, North Carolina. Dr. Monahan is highly rated in 4 conditions, according to our data. His top areas of expertise are Hemophilia B, Blood Clots, Hemophilia A, and Hemophilic Arthropathy.

Jennifer Rothman
Expertise in
11
conditions
Dr. Jennifer Rothman
Pediatric Hematology Oncology
Expertise in
11
conditions
Dr. Jennifer Rothman
Pediatric Hematology Oncology
2100 Erwin Rd, 
Durham, NC 
 (0.2 miles away)
919-684-8111
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jennifer Rothman is a Pediatric Hematologist Oncology provider in Durham, North Carolina. Dr. Rothman is highly rated in 11 conditions, according to our data. Her top areas of expertise are Pyruvate Kinase Deficiency, Anemia, Hemolytic Anemia, Congenital Hemolytic Anemia, and Splenectomy.

VIEW MORE Pediatric Hematologist Oncologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kurtzberg's expertise for a condition
ConditionClose
      • Advanced
      • Congenital Athymia
        Dr. Kurtzberg is
        Advanced
        . Learn about Congenital Athymia.
        See more Congenital Athymia experts
      • Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)
        Dr. Kurtzberg is
        Advanced
        . Learn about Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome).
        See more Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome) experts
      • Experienced
      • Anemia
        Dr. Kurtzberg is
        Experienced
        . Learn about Anemia.
        See more Anemia experts
      • Autism Spectrum Disorder
        Dr. Kurtzberg is
        Experienced
        . Learn about Autism Spectrum Disorder.
        See more Autism Spectrum Disorder experts
      • Childhood Acute Myeloid Leukemia
        Dr. Kurtzberg is
        Experienced
        . Learn about Childhood Acute Myeloid Leukemia.
        See more Childhood Acute Myeloid Leukemia experts
      • Chronic Graft Versus Host Disease (cGvHD)
        Dr. Kurtzberg is
        Experienced
        . Learn about Chronic Graft Versus Host Disease (cGvHD).
        See more Chronic Graft Versus Host Disease (cGvHD) experts
      • Infantile Neutropenia
        Dr. Kurtzberg is
        Experienced
        . Learn about Infantile Neutropenia.
        See more Infantile Neutropenia experts
      • Neonatal Sepsis
        Dr. Kurtzberg is
        Experienced
        . Learn about Neonatal Sepsis.
        See more Neonatal Sepsis experts
      View All 8 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      1. Homepage
      2. Pediatric Hematologist Oncologists Durham, NC
      3. Dr. Joanne J. Kurtzberg
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.